- Previous Close
107.75 - Open
106.00 - Bid 101.60 x --
- Ask 102.01 x --
- Day's Range
100.49 - 109.76 - 52 Week Range
85.55 - 169.00 - Volume
126,116 - Avg. Volume
49,971 - Market Cap (intraday)
26.084B - Beta (5Y Monthly) 0.89
- PE Ratio (TTM)
8.30 - EPS (TTM)
12.24 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield 2.40 (2.23%)
- Ex-Dividend Date Aug 5, 2024
- 1y Target Est
--
Alembic Limited engages in real estate business in India and internationally. It operates through Active Pharmaceutical Ingredient (API) and Real Estate segments. The company constructs residential and commercial real estate projects; provision of project management and marketing consultancy services; and leasing of commercial properties. It manufactures and markets fermentation and chemistry based on active pharmaceutical ingredient; and engages in research and development. In addition, it is involved in power generation through co-generation plants and wind power sources. The company serves individuals, corporates, business houses, and pharmaceutical companies. The company was founded in 1907 and is based in Vadodara, India. Alembic Limited is a subsidiary of Nirayu Pvt. Ltd.
www.alembiclimited.com285
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: ALEMBICLTD.BO
View MorePerformance Overview: ALEMBICLTD.BO
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALEMBICLTD.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALEMBICLTD.BO
View MoreValuation Measures
Market Cap
27.67B
Enterprise Value
27.37B
Trailing P/E
8.80
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
13.82
Price/Book (mrq)
1.23
Enterprise Value/Revenue
13.67
Enterprise Value/EBITDA
16.64
Financial Highlights
Profitability and Income Statement
Profit Margin
149.23%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
2.11B
Net Income Avi to Common (ttm)
3.14B
Diluted EPS (ttm)
12.24
Balance Sheet and Cash Flow
Total Cash (mrq)
427.7M
Total Debt/Equity (mrq)
0.72%
Levered Free Cash Flow (ttm)
--